Why the study?
Does sublingual vaccination with killed serotype Asia 1 FMDV vaccine prevent clinical disease in guinea pigs challenged with homologous FMDV?
Does sublingual vaccination with killed serotype Asia 1 FMDV vaccine prevent clinical disease in guinea pigs challenged with homologous FMDV?
Sublingual administration of FMDV vaccine at reduced doses provides effective protection against foot-and-mouth disease in a guinea pig model.
Answers are grounded in this paper and cite their sources.
Supports sublingual dose-sparing in FMDV models; leaves open translation to livestock and field use.
Foot-and-mouth disease virus (FMDV) causes vesicular disease of cloven-hoofed animals, with severe agricultural and economic losses. Here we present study using a sublingual (SL) route with the killed serotype Asia 1 FMDV vaccine. Guinea pigs were vaccinated using a commercially available vaccine formulation at the manufacturer's recommended full, 1/4, and 1/16 antigen doses. Animals were challenged with homologous FMDV Asia1 strain at various times following vaccination. All control guinea pigs exhibited clinical disease, including fever, viremia, and lesions, specifically vesicle formation in feet. Animals vaccinated with the 1/16 and 1/4 doses were protected after challenge at days 7, 28, and 35 post vaccination. These data suggest that effective protection against foot-and-mouth disease can be achieved with 1/16 of the recommended vaccine dose using SL vaccination, indicating that the sublingual route is an attractive alternative for the administration of the FMDV vaccine.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: